Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes

The results suggest that the higher DOX concentration mainly induces p53-dependent apoptosis, whereas for the lower DOX concentration the cardiotoxic effects involve bioenergetic failure, unveiling PDH as a possible therapeutic target to decrease DOX cardiotoxicity.